Marburg virus disease in Rwanda: an observational study of the first 10 days of outbreak response, clinical interventions, and outcomes
Abstract Background Marburg virus disease (MVD) is a highly fatal hemorrhagic fever with fatality rates between 33 and 88% in sub-Saharan Africa. Rwanda reported its first MVD outbreak on September 27, 2024. This study assessed Rwanda’s response to its first MVD outbreak, focusing on identifying cri...
Saved in:
| Main Authors: | Gashaija Absolomon, Canita R. Brent, Emmanuel C. Nyabyenda, Kelly Mwiza, Piero Irakiza, Zuki Chiwandire, Caroline Mudereri, Nathalie Umutoni, Sabine Musange, Eric Seruyange, Felix K. Rubuga, Theogene Twagiramugabe, Sanctus Musafiri, Edson Rwagasore, Jeanine Condo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04123-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kinetics of hematological and biochemical biomarkers are key tools for monitoring disease progression in Marburg virus-infected patients in Rwanda
by: Jean Claude Mugisha, et al.
Published: (2025-07-01) -
Marburg Virus Disease: A Narrative Review
by: Arash Letafati, et al.
Published: (2025-05-01) -
Prevalence and determinants of hypertension in rwanda: a secondary data analysis using the WHO STEPS survey 2022
by: Jean Damascene Hagenimana, et al.
Published: (2025-08-01) -
Marburg haemorrhagic fever: A rare but fatal disease
by: G.A. Ogunbanjo
Published: (2005-05-01) -
A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice
by: Jinhao Bi, et al.
Published: (2023-12-01)